Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
AARD
LENZ
Add up to 3 more stocks
AARD
Aardvark Therapeutics, Inc. Common Stock
-3.45%
$5.04-0.18Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$110.30M
52W Range
$3.35 - $17.94
LENZ
LENZ Therapeutics, Inc.
+5.57%
$3.79+0.20Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$118.83M
52W Range
$3.46 - $49.25
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 1.47 | 0.54 |
| P/S Ratio | N/A | 5.53 |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 0.0% | 90.1% |
| Operating Margin | 0.0% | -477.5% |
| Net Margin | 0.0% | -586.7% |
| ROE | -93.4% | -57.5% |
| ROA | -85.8% | -53.3% |
| ROIC | -98.0% | -61.8% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 12.63 | 13.55 |
| Quick Ratio | 12.63 | 13.31 |
| Debt/Equity | 0.01 | 0.00 |
| Interest Coverage | N/A | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.